Only logged in customers who have purchased this product may leave a review.
OLYMPUS LABS RE1GN – VER. AGMASS US Pre-workout
£32.87
Re1gn Pre-Workout
by Olympus Labs
Re1gn is a powdered food supplement formulated as an advanced pre-training blend. The formula combines amino acids, patented plant-derived compounds, stimulant-related ingredients, and nootropic-style components in a multi-scoop format.
This product is intended for experienced users who are familiar with complex, high-intensity pre-workout formulations and structured training routines.
Formula Overview
A multi-ingredient composition built around components commonly used in premium pre-workout products:
-
L-Citrulline / Citrulline Malate
-
AGMass® (Augments, fermentation-derived compounds)
-
Vaso6® (grape seed-derived oligomers)
-
Eria Jarensis Extract
-
TeaCrine® (theacrine)
-
KannaEase® (Sceletium tortuosum extract)
* Daily Values not established.
Directions for Use
Mix 2 scoops with water and consume approximately 30 minutes before training.
Users new to stimulant-based pre-workouts should consider starting with a reduced serving to assess individual tolerance.
-
Do not exceed the recommended daily intake
-
Intended for adult use only
Product Notes
-
Powder-based pre-training formula
-
Includes patented raw materials and branded ingredients
-
Multi-scoop dosing format
-
Designed for experienced users only
-
Not suitable for stimulant-sensitive individuals
Disclaimer
This product is a food supplement and should not be used as a substitute for a varied and balanced diet or a healthy lifestyle. Do not exceed the recommended daily intake. Keep out of reach of children. Not recommended during pregnancy or breastfeeding. If you are taking medication or have a medical condition, consult a qualified professional before use. Discontinue use if any adverse reactions occur. Store in a cool, dry place away from direct sunlight.
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.